Long-Term Safety and Efficacy Evaluation of EPI-743 in Children With Leigh Syndrome
Study sponsor: PTC Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-10-30Actual
Enrollment · participants30Actual
Source updated2024-10-23Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.